Jan 9, 2025, 01:00 AM by User Not Found

Bio-IT World | Looming uncertainties tied to the upcoming U.S. administration change will affect many key areas of artificial intelligence (AI) in 2025, according to Mark Dredze, interim deputy director for the Data Science and AI Institute at Johns Hopkins University. While a focus on deregulation appears likely, exactly how things will play out for AI governance and policy is anyone’s guess.

Jan 8, 2025, 07:53 AM by

Following an expanded collaboration between AI innovator Quris-AI and Merck KGaA and a two-year validation study to test clinical safety prediction by identifying drug candidate liver toxicity risks, it was announced this morning that Merck KGaA has adopted the startup's platform to test small molecule drug candidates prior to initiating clinical trials. Quris-AI’s platform integrates advanced AI, machine learning, generative models, patient-on-chip technology, and proprietary data to predict potential drug-induced toxicities better.

Jan 8, 2025, 07:53 AM by

ClearNote Health announced that its Avantect Multi-Cancer Detection Test was selected for the National Cancer Institute’s new Vanguard Study.

Jan 8, 2025, 01:00 AM by User Not Found

Bio-IT World | The placenta is a temporary but critical organ everyone needs to initiate their life, yet it remains one of the most understudied organs in human biology despite the possible lifelong health implications if anything it is supposed to do goes awry.

Jan 7, 2025, 01:00 AM by User Not Found

Bio-IT World | 2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to anticipate in the new year. Here are the full trends and predictions, including more on AI/ML, multimodal data, drug discovery, new policies, spatial biology, and more.

Jan 3, 2025, 01:00 AM by User Not Found

Bio-IT World | Last year, the world of biotech achieved much with AI, sequencing, treatment development, and more. The Trends from the Trenches podcast also covered data management strategies, embracing change, and the technologies driving data-intensive science. To kick off the new year, here are the top stories and top podcast episodes of 2024 from Bio-IT World and Trends from the Trenches.

Dec 30, 2024, 01:00 AM by User Not Found

Bio-IT World | What role will AI play in the future of drug development, especially as novel therapeutic approaches such as precision medicine drive up the complexity and cost of research? Some industry headlines hype AI as a magic bullet, capable of cutting through the headwinds of slow development cycles, shifting regulations, and high rates of failure. For companies racing to reach the market with safe and compliant new drug products, this vision of AI is compelling—and it’s driving heavy investment.

Dec 27, 2024, 01:00 AM by User Not Found

Bio-IT World | BC Platforms enters an extended joint partnership with the University of Nottingham and Nottingham University Hospitals NHS Trust to provide data sharing platforms and tools; Certis Oncology Solutions launches CertisOI Assistant, an innovative chatbot tool ; and more.

Dec 23, 2024, 08:26 AM by User Not Found

Bio-IT World | AQEMIA intends to teach its generative AI platform quantum-inspired, atomic-scale physics to transform drug discovery; DeepLife plans to develop AI-powered models of human cells, known as digital twins of cells, for drug discovery; and more.

Dec 19, 2024, 11:12 AM by

ClearNote’s Avantect Pancreatic Cancer test was selected for a large UK NHS study that will include up to 15,000 patient participants recently diagnosed with type 2 diabetes. The Avantect test is a blood-based assay designed to use key epigenomic and genomic signals to detect the earliest indicators of pancreatic cancer.

Dec 18, 2024, 08:39 AM by

Integration between eClinical’s elluminate Clinical Data Cloud and Snowflake offers modern data architecture to power clinical data science and AI, unlock data value for healthcare outcomes

Dec 18, 2024, 08:39 AM by

- Intelliguard, a leading provider of medication, inventory management and data-intelligence solutions, today announced the appointment of Giovanni Sapio as Chief Financial Officer, along with several other key executive leadership changes. These strategic moves mark a significant milestone in Intelliguard's growth journey, coinciding with the launch of its Client Excellence Organization, designed to further elevate client satisfaction and operational efficiency.

Dec 18, 2024, 08:38 AM by

Oxford Nanopore Technologies will participate in a groundbreaking study will analyse the entire genetic code of up to 17,000 people with Myalgic Encephalomyelitis (ME) in a bid to uncover the genetic causes of the illness.

Dec 18, 2024, 01:00 AM by User Not Found

Bio-IT World | In a Perspectives paper published last week in Cell, researchers from Stanford University, Genentech, and the Chan-Zuckerberg Initiative issued a call for AI to build a virtual cell. Technology is ripe for a biologically-valuable virtual cell, they say, outlining their views of the priorities and opportunities.

Dec 17, 2024, 09:06 AM by User Not Found

Bio-IT World | It has been a momentous year for artificial intelligence and machine learning. AI models can simulate clinical trials, diagnose diseases early, and detect biomarkers, and there is still no shortage of innovative ideas. However, there are some concerns surrounding AI/ML that have also been at the forefront of the industry. The latest episode of Trends from the Trenches covers one of these concerns.

Dec 16, 2024, 08:12 AM by

Concinnity Genetics, an Edinburgh-based gene control company, is thrilled to announce the closure of its oversubscribed £3m seed funding round. The investment was led by Eos Advisory with support from Scottish Enterprise, Old College Capital (OCC) – the University of Edinburgh’s in-house venture investment fund, and Maven Capital Partners.

Dec 16, 2024, 08:12 AM by

BC Platforms, a global leader in real-world data, healthcare data management, and analytics, has announced an extended, joint partnership with the University of Nottingham (UoN) and Nottingham University Hospitals NHS Trust (NUH) to provide data-sharing platforms and tools facilitating data sharing, security, and advanced analyses including Trusted Research Environments (TREs*). The outputs of analysing such data, from both clinical and basic research, have the potential to transform our understanding of important healthcare trends, as well as studying devastating diseases such as cancer and diabetes up to the population level. They could also potentially help unlock innovative new solutions and therapies for patients everywhere.

Dec 13, 2024, 07:55 AM by

Coronado Research announced today that Dr Jennifer Bradford has been appointed as VP, Head of Data Science.

Dec 13, 2024, 07:55 AM by

VieCure announced Commonwealth Cancer Center will deploy its Halo Intelligence platform - the first AI-enabled community oncology care solution. Clinicians will use the platform to manage precision oncology data and help determine the optimal personalized treatment path for patients across rural Kentucky.

Dec 13, 2024, 01:00 AM by User Not Found

Bio-IT World | Japan has long taken a leadership role in the pursuit of boron neutron capture therapy (BNCT) as a treatment for cancer. The approach involves injecting patients with a boron-containing compound that accumulates in tumor cells and acts as an exclusive target for neutrons to kill and was the research focus of a pair of Harvard scientists throughout the 1950s.